News Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
- Dec 06, 2018
Dallas, TX, December 6, 2018 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, today announced that its Board of Directors...
- Nov 12, 2018Total revenues of approximately $5.9 million for the third quarter of 2018 compared to $5.5 million for the third quarter of 2017.
Dallas, TX, November 12, 2018 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its third quarter 2018 financial...
- Nov 01, 2018DxTerity will present on Thursday, November 15, 2018 at 11:30 a.m. PT (2:30 p.m. ET) in New York
Los Angeles, CA, November 1, 2018 – DxTerity, a molecular information and diagnostics company developing at-home RNA monitoring blood tests for immune-mediated diseases, today announced that...
- Oct 21, 2018Autoimmune Profile Test (AIP) shows promise for stratifying patients based on Type I interferon expression levels
Los Angeles, CA, October 21, 2018 – DxTerity, a molecular information and diagnostics company developing at-home RNA monitoring blood tests for immune-mediated diseases, today announced that...
- Sep 24, 2018
DxTerity CEO & Founder Bob Terbrueggen will be speaking at two upcoming conferences in October: World CB & CDx in Boston, MA and Precision Medicine in Autoimmunity in Denver, CO. Dr. Terbrueggen...
- Sep 19, 2018Total revenues of approximately $6.8 million for the second quarter of 2018 compared to $6.1 million for the second quarter of 2017.
Dallas, TX, August 10, 2018 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its second quarter 2018 financial...
- Aug 31, 2018
Los Angeles, CA – PM360, a publication for marketing decision markers in the pharmaceutical, biotech, and medical device industries, recently named DxTerity’s EMPOWER Study Recruitment as a...
- Jul 02, 2018
Dallas, TX, July 2, 2018 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced that it has closed a $20 million...
- Jun 07, 2018Presentations from the >1,400 LIFT Study Lupus Cohort
Los Angeles, CA, June 13, 2018 – DxTerity, a patient-centric genomics company developing at-home RNA monitoring blood tests for immune-mediated diseases, today announced that data from the LIFT...
- May 28, 2018REDI-Dx® blood test to estimate absorbed radiation after a nuclear event
LOS ANGELES, CA – May 28, 2018 – DxTerity Diagnostics has declared conformity with the requirements of the European In Vitro Diagnostic Directive (98/79/EC) and has applied the CE mark to the...
- May 01, 2018
May is Lupus Awareness Month, sponsored by organizations like Lupus Foundation of America, Lupus LA, and The Lupus Research Alliance. DxTerity is proud to support these organizations in advancing...
- Apr 30, 2018
This May 1 and May 2, 2018, the Young Jewish Professionals Organization is hosting its annual CEO Healthcare Symposium in New York City, NY, and Bob Terbrueggen, DxTerity Founder & CEO, will be...
- Mar 29, 2018Total revenues of $37.5 million for the fiscal year 2017 compared to $22.4 million for the fiscal year 2016.
Dallas, TX, March 29, 2018 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its fourth quarter and full year...
- Mar 29, 2018
The following tables provide a reconciliation of SWK’s reported (GAAP) income before provision for income tax to SWK’s adjusted net income attributable to SWK Holdings Corporation stockholders...
- Mar 15, 2018Total revenues of $6.8 million for the first quarter of 2018 compared to $14.9 million for the first quarter of 2017.
Dallas, TX, May 14, 2018 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its first quarter 2018 financial results.
- Jan 17, 2018
The Precision Medicine World Conference (PMWC) 2018 will take place in Silicon Valley on January 22-24, 2018. This year, we’re excited to announce that DxTerity Founder & CEO Bob Terbrueggen...
- Nov 10, 2017Total revenues of approximately $5.5 million for the third quarter of 2017 compared to $4.2 million for the third quarter of 2016.
Dallas, TX, November 10, 2017 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its third quarter 2017 financial...
- Nov 05, 2017
DxTerity, a patient-centric genomics company developing at-home genomic monitoring blood tests for immune mediated diseases, today announced that data on the BRAVO Study in which participants with...
- Sep 21, 2017
DxTerity announced today that it is collaborating with the City of Hope Medical Center on the clinical development of a blood test that could possibly predict whether cancer patients about to...
- Aug 14, 2017Total revenues of approximately $6.1 million for the second quarter of 2017 compared to $8.6 million for the second quarter of 2016.
Dallas, TX, August 10, 2017 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its second quarter 2017 financial...
- May 10, 2017Total revenues of approximately $14.9 million for the first quarter of 2017 compared to $5.2 million for the first quarter of 2016.
Dallas, TX, May 10, 2017 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its first quarter 2017 financial results.
- Mar 18, 2017Total revenues of $22.4 million for the fiscal year 2016 compared to $23.5 million for the fiscal year 2015
Dallas, TX, March 17, 2017 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its fourth quarter and full year...
- Nov 10, 2016Total revenues of $4.2 million for the third quarter of 2016 compared to $5.7 million for the third quarter of 2015
Dallas, TX, November 8, 2016 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its third quarter 2016 financial...
- Oct 24, 2016
(Los Angeles, CA) – DxTerity Diagnostics announced today that it has signed a multi-year contract with the Biomedical Advanced Research and Development Authority (BARDA), which is a division of...
- Aug 12, 2016Total revenues of $8.6 million for the three months ended June 2016 compared to $5.4 million for the second quarter of 2015
Dallas, TX, August 10, 2016 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its second quarter 2016 financial...